BPC-157 relieved knee pain for 90% of patients, past 6 months

June 17, 2026

Last updated: June 21, 2026

BPC-157 was tested on human knees. Not rats. Humans. 16 patients. Real knee pain. Osteoarthritis. Meniscus tears. Ligament damage.

Their doctors gave them two options: cortisone or surgery. They got BPC-157 instead. 90% reported pain relief. Not for a week. Not for a month. Past 6 MONTHS. (PMID: 34324435)

Every time someone says “it’s just rat studies” — show them this. Cortisone numbs pain for 3 weeks then BREAKS DOWN the collagen holding your knee together. You pay $500 to accelerate the damage.

Surgery costs $15,000-50,000. Months of recovery. And most knees are never the same.

BPC-157 grows new blood vessels into the damage. Builds fresh collagen. Activates repair your body stopped sending. → 90% pain relief past 6 months → no surgery → no cortisone → no side effects reported→ a peptide your stomach already makes

16 patients. 90% success. Published. Peer-reviewed. Your orthopedic surgeon charges $30,000 and gives you a 60% chance. BPC-157 cost a fraction and hit 90%.

Grok:

The post cites a 2021 retrospective study (PMID 34324435) on 16 human patients with knee osteoarthritis, meniscus tears, and ligament damage who received intra-articular BPC-157 injections; 11 of 12 in the BPC-157-only group reported significant pain relief lasting over 6 months.

This small open-label study lacked controls, blinding, standardized pain scales, or follow-up imaging, making it preliminary despite the high reported success rate versus typical cortisone or surgery options discussed.

BPC-157, a gastric peptide fragment, shows strong regenerative effects like angiogenesis and collagen repair in animal models across tissues, but human data remains limited to a few small studies; the post promotes oral tablets from a linked seller for systemic use.

Source (X): https://x.com/HealthyAlfred/status/2056326622865703098?s=20